Biology Reference
In-Depth Information
Sasaki T, Yuasa K, Omori K (2000) Identification of human PDE7B, a cAMP specific phosphodi-
esterase. Biochem Biophys Res Comm 271:575-583
Sasaki T, Kotera J, Omori K (2002) Novel alternative splice variants of rat phosphodiesterase 7B
showing unique tissue-specific expression and phosphorylation. Biochem J 361:211-220
Sasaki T, Kotera J, Omori K (2004) Transcriptional activation of phosphodiesterase 7B1
by dopamine D1 receptor stimulation through the cyclic AMP/cyclic AMP-dependent protein
kinase/cyclic AMP-response element binding protein pathway in primary striatal neurons.
J Neurochem 89:474-483
Schaak S, Cayla C, Lymperopoulos A, Flordellis C, Cussac D, Denis C, Paris H (2000) Transcrip-
tional down-regulation of the human alpha2C-adrenergic receptor by cAMP. Mol Pharmacol
58:821-827
Schmidt CJ (2010) Phosphodiesterase inhibitors as potential cognition enhancing agents. Curr Top
Med Chem 10:222-230
Seeger TF, Bartlett B, Coskran TM, Culp JS, James LC, Krull DL, Lanfear J, Ryan AM, Schmidt
CJ, Strick CA, Varghese AH, Williams RD, Wylie PG, Menniti FS (2003) Immunohistochemi-
cal localization of PDE10A in the rat brain. Brain Res 985:113-126
Sette C, Iona S, Conti M (1994) The short-term activation of a rolipramsensitive, cAMP-specific
phosphodiesterase by thyroid-stimulating hormone in thyroid FRTL-5 cells is mediated by a
cAMP-dependent phosphorylation. J Biol Chem 269:9245-9252
Singh N, Parle M (2003) Sildenafil improves acquisition and retention of memory in mice. Indian
J Physiol Pharmacol 47:318-324
Siuciak JA (2008) The role of phosphodiesterases in schizophrenia: therapeutic implications. CNS
Drugs 22:983-993
Siuciak JA, McCarthy SA, Chapin DS, Fujiwara RA, James LC, Williams RD, Stock JL, McNeish
JD, Strick CA, Menniti FS, Schmidt CJ (2006) Genetic deletion of the striatum-enriched
phosphodiesterase PDE10A: evidence for altered striatal function. Neuropharmacology 51:
374-385
Siuciak JA, Chapin DS, McCarthy SA, Martin AN (2007) Antipsychoticprofole of rolipram:
efficacy in rat and reduced sensitivity in mice deficient in the phosphodiesterase-4B(PDE4B)
enzyme. Psychopharmacology (Berl) 192:415-424
Siuciak JA, McCarthy SA, Chapin DS, Martin AN (2008) Behavioral and neurochemical characteri-
zation of mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology
197:115-126
Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G, Schaffner S, Kirov G,
Jones I, Owen M, Craddock N, DePaulo JR, Lander ES (2002) Family-based association
study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol Psychiatry
7:579-593
Smith SJ, Cieslinski LB, Newton R, Donnelly LE, Fenwick PS, Nicholson AG, Barnes PJ,
Barnette MS, Giembycz MA (2004) Discovery of BRL 50481 [3-(N, N-dimethylsulfona-
mido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies
in human monocytes, lung macrophages, and CD8
รพ
T-lymphocytes. Mol Pharmacol 66:
1679-1689
Soderling SH, Bayuga SJ, Beavo JA (1999) Isolation and characterization of a dual-substrated
phosphodiesterase gene family: PDE10A. Proc Natl Acad Sci USA 96:7071-7076
Souness JE, Aldous D, Sargent C (2000) Immunosuppressive and antiinfl ammatory effects of
cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology 47:127-162
Ster J, de Bock F, Bertaso F, Abitbol K, Daniel H, Bockaert J, Fagni L (2009) Epac mediates
PACAP-dependent long-term depression in the hippocampus. J Physiol 587:101-113
Strick CA, James LC, Fox CB, Seeger TF, Menniti FS, Schmidt CJ (2010) Alterations in
gene regulation following inhibition of the striatum-enriched phosphodiesterase, PDE10A.
Neuropharmacology 58:444-451
Surapisitchat J, Jeon KI, Yan C, Beavo JA (2007) Differential regulation of endothelial cell
permeability by cGMP via phosphodiesterases 2 and 3. Circ Res 101:811-818
